Related Experiment Video
Updated: Dec 29, 2025

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Prenatal exposure to bisphenol A and its alternatives and child neurodevelopment at 2 years
Yangqian Jiang1, Jiufeng Li2, Shunqing Xu3
1Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Insights
Prenatal exposure to bisphenol S (BPS) is linked to lower child psychomotor development. Bisphenol A (BPA) exposure in the second trimester also negatively impacts infant mental development, while bisphenol F (BPF) showed no significant effects.
Area of Science:
- Environmental Health
- Developmental Toxicology
- Neuroscience
Background:
- Growing evidence links prenatal bisphenol A (BPA) exposure to adverse child neurodevelopmental outcomes.
- Limited data exists on the neurodevelopmental effects of common BPA alternatives like bisphenol S (BPS) and bisphenol F (BPF).
Purpose of the Study:
- To investigate the association between repeated prenatal exposure to BPA, BPS, and BPF and child neurodevelopmental outcomes.
- To assess neurodevelopmental effects at 2 years of age in relation to maternal urinary bisphenol concentrations across trimesters.
Main Methods:
- Longitudinal study of 456 mother-child pairs from 2014-2015.
- Maternal spot urine samples collected in each trimester for BPA, BPS, and BPF analysis.
- Child neurodevelopment assessed at 2 years using the Bayley Scales of Infant Development.
Main Results:
- Higher prenatal BPS exposure was associated with decreased psychomotor development index scores (P-trend=0.01).
- Second-trimester BPA exposure was linked to lower mental development index scores (P-trimester-interaction=0.04).
- No significant associations were found between prenatal BPF exposure and child neurodevelopment.
Conclusions:
- Prenatal exposure to BPA and BPS may negatively impact child neurodevelopment.
- BPS and BPA represent potential environmental risks to neurodevelopment, warranting further investigation and public health consideration.
Abstract:
While increasing evidence has shown that prenatal bisphenol A (BPA) exposure is adversely associated with child neurodevelopment, little is known about the neurodevelopmental effects of BPA alternatives, such as bisphenol S (BPS) and bisphenol F (BPF). We aimed to evaluate the relationships of repeated measurements of bisphenol exposure during pregnancy with child neurodevelopment. From 2014-2015, 456 mother-child pairs were included in the present study. Each had a spot urine sample in the first, second, and third trimester, respectively, during pregnancy for BPA, BPS, and BPF measurements. Children's neurodevelopment was assessed using the Bayley Scales of Infant Development at 2 years. In adjusted models, children's psychomotor development index scores decreased across quartiles of BPS concentrations [-5.52 (95 % CI: -10.06, -0.99) in the 4th quartile vs. 1 st quartile, P-trend = 0.01]. Each 10-fold increase in BPA concentrations was related to lower mental development index scores only in the second trimester [-2.87 (95 % CI: -4.98, -0.75), Ptrimester-int = 0.04]. However, prenatal BPF exposure was not significantly associated with child neurodevelopment. We provide evidence that prenatal exposure to BPA and BPS may affect child neurodevelopment.
More Related Videos
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Related Concept Videos
Teratogenicity
Pharmacokinetics in Pediatric Patients: Drug Metabolism